A retro-inverso peptide mimic of CD28 encompassing the MYPPPY motif adopts a polyproline type II helix and inhibits encephalitogenic T cells in vitro

被引:29
作者
Srinivasan, M
Wardrop, RM
Gienapp, IE
Stuckman, SS
Whitacre, CC
Kaumaya, PTP
机构
[1] Ohio State Univ, Coll Med Obstet & Gynecol, Ctr Comprehens Canc, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Biol Sci, Dept Microbiol, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Med & Publ Hlth, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
[4] Ohio State Univ, Coll Med & Publ Hlth, Dept Obstet & Gynecol, Columbus, OH 43210 USA
关键词
D O I
10.4049/jimmunol.167.1.578
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Complete activation of T cells requires two signals: an Ag-specific signal delivered via the TCR by the peptide-MHC complex and a second costimulatory signal largely provided by B7:CD28/CTLA-4 interactions. Previous studies have shown that B7 blockade can either ameliorate experimental autoimmune encephalomyelitis by interfering with CD28 signaling or exacerbate the disease by concomitant blockade of CTLA-4 interaction. Therefore, we developed a functional CD28 mimic to selectively block B7:CD28 interactions. The design, synthesis, and structural and functional properties of the CD28 free peptide, the end group-blocked CD28 peptide, and its retro-inverso isomer are shown. The synthetic T cell-costimulatory receptor peptides fold into a polyproline type II helical structure commonly seen in regions of globular proteins involved in transient protein-protein interactions. The binding determinants of CD28 can be transferred onto a short peptide mimic of its ligand-binding region. The CD28 peptide mimics effectively block the expansion of encephalitogenic T cells in vitro suggesting the potential usefulness of the peptides for the treatment of autoimmune disease conditions requiring down-regulation of T cell responses. The Journal of Immunology, 2001.
引用
收藏
页码:578 / 585
页数:8
相关论文
共 51 条
[1]   The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system [J].
Anderson, DE ;
Sharpe, AH ;
Hafler, DA .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (06) :677-683
[2]   Bactericidal activity and poly-L-proline II conformation of the tandem repeat sequence of human salivary mucin glycoprotein (MG2) [J].
Antonyraj, KJ ;
Karunakaran, T ;
Raj, PA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 356 (02) :197-206
[3]   Molecular modeling of CD28 and three-dimensional analysis of residue conservation in the CD28/CD152 family [J].
Bajorath, J ;
Metzler, WJ ;
Linsley, PS .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1997, 15 (02) :135-&
[4]  
Benson JM, 1999, J IMMUNOL, V162, P6247
[5]   CD28 AND APOPTOSIS [J].
BOISE, LH ;
NOEL, PJ ;
THOMPSON, CB .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (05) :620-625
[6]   CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L) [J].
BOISE, LH ;
MINN, AJ ;
NOEL, PJ ;
JUNE, CH ;
ACCAVITTI, MA ;
LINDSTEN, T ;
THOMPSON, CB .
IMMUNITY, 1995, 3 (01) :87-98
[7]   Costimulatory regulation of T cell function [J].
Chambers, CA ;
Allison, JP .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) :203-210
[8]   Oral tolerance in myelin basic protein T-cell receptor transgenic mice: Suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells [J].
Chen, YH ;
Inobe, J ;
Kuchroo, VK ;
Baron, JL ;
Janeway, CA ;
Weiner, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :388-391
[9]   RECENT DEVELOPMENTS IN RETRO PEPTIDES AND PROTEINS - AN ONGOING TOPOCHEMICAL EXPLORATION [J].
CHOREV, M ;
GOODMAN, M .
TRENDS IN BIOTECHNOLOGY, 1995, 13 (10) :438-445
[10]  
Ellis JH, 1996, J IMMUNOL, V156, P2700